LFMD Earnings Prediction
The chart below shows how LFMD performed 10 days before and after its earnings report, based on data from the past quarters. Typically, LFMD sees a -0.65% change in stock price 10 days leading up to the earnings, and a +1.20% change 10 days following the report. On the earnings day itself, the stock moves by +0.78%. This data can give you a slight idea of what to expect for the next quarter's release.
LFMD Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
53.39M
38.27%
5.39%
Gross Margin
90.61%
3.41%
0.59%
Operating Margin
-8.78%
-25.78%
-29.48%
Net Margin
-10.26%
-25.00%
-24.00%
EPS
-0.14
-30.00%
-26.32%
No Data Available
LFMD Earnings Analysis
LifeMD, Inc. Common Stock Corporation (LFMD.O) Earnings Conference Call
Positive
Strong Revenue Growth: LifeMD achieved a very strong third quarter performance with total revenues growing 38% versus the year ago period to $53.4 million.
Telehealth Revenue Surge: Core telehealth revenue grew by 65% versus the prior year with standalone adjusted EBITDA profitability at $2.5 million, which was up 200% sequentially versus the second quarter.
Telehealth Subscriber Surge: Telehealth subscriber growth remained strong with the number of active subscribers increasing 30% year-over-year to approximately 269,000 at quarter end.
Gross Profit Surge: Gross profit was $48.4 million, an increase of 43% from the year ago period, with gross margin for the telehealth business increasing by 770 basis points year-over-year to a record 89.3%.
Cash Flow Performance: LifeMD generated over $6.2 million of cash flow from operations during the third quarter of 2024 and exited the third quarter with $37.6 million in cash.
Negative
Quarterly Net Loss Comparison: Lifemd's GAAP net loss attributable to common stockholders for the third quarter was $5.9 million or a loss of $0.14 per share, compared to a GAAP net loss attributable to common stockholders for the third quarter of 2023 of $6.9 million or $0.20 per share.
Subscriber Growth Recovery: The number of WorkSimplic active subscribers contracted 6% to 161,000, but returned to sequential growth, reflecting what we believe is a sustained turning point in WorkSimplic's performance.
EBITDA Increase Quarter-over-Year: Lifemd's adjusted EBITDA totaled $3.7 million for the third quarter as compared with $2.8 million in the year ago period.
Telehealth Revenue Guidance Increase: The company is raising telehealth revenue guidance to be between $151 million and $152 million, up from $150 million previously.
Adjusted EBITDA Forecast: The company expects to total adjusted EBITDA, however, including the impact of WorkSimplic consolidation to be in the narrowed range of $13 million to $14 million from the previous range of $13 million to $15 million.
LFMD FAQs
How does LFMD typically perform around its earnings report dates?
Is LifeMD, Inc. (LFMD) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
LFMD Earning Call Sentiment
LifeMD, Inc. (LFMD) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
LFMD.O
-2.62%Positive
LifeMD's earnings call presents a positive outlook with strong financial performance, increased revenue guidance, and a significant rise in telehealth subscribers. The company is optimistic about future agreements improving accessibility to GLP-1 therapies. Despite some concerns about supply chain challenges and economic factors, the Q&A session revealed confidence in growth drivers and strategic plans. Positive cash flow and a strong cash position further bolster sentiment. The raised guidance and improved financial metrics suggest a positive stock price movement over the next two weeks.
